206 related articles for article (PubMed ID: 18573939)
21. Programmed death 1 receptor changes ex vivo in HIV-infected adults following initiation of highly active antiretroviral therapy.
Spitsin S; Tustin NB; Riedel E; Tustin R; Murray JB; Peck LM; Khan M; Quinn J; Douglas SD
Clin Vaccine Immunol; 2012 May; 19(5):752-6. PubMed ID: 22441393
[TBL] [Abstract][Full Text] [Related]
22. Impaired restoration of plasmacytoid dendritic cells in HIV-1-infected patients with poor CD4 T cell reconstitution is associated with decrease in capacity to produce IFN-alpha but not proinflammatory cytokines.
Sachdeva N; Asthana V; Brewer TH; Garcia D; Asthana D
J Immunol; 2008 Aug; 181(4):2887-97. PubMed ID: 18684980
[TBL] [Abstract][Full Text] [Related]
23. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients.
Santinelli L; Statzu M; Pierangeli A; Frasca F; Bressan A; Pinacchio C; Nonne C; Turriziani O; Antonelli G; d'Ettorre G; Scagnolari C
Cytokine; 2019 Aug; 120():273-281. PubMed ID: 30910260
[TBL] [Abstract][Full Text] [Related]
25. [Innate immunity restoration in patients with HIV/AIDS infection associated with antiretroviral therapy].
Afani A; Jiusán L; Raby P; Sitia G; Puente J; Sepúlveda C; Miranda D; Cabrera R; Guidotti L; Lanza P
Rev Med Chil; 2006 Jun; 134(6):689-96. PubMed ID: 17130942
[TBL] [Abstract][Full Text] [Related]
26. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
27. Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission.
Lafeuillade A; Poggi C; Chadapaud S; Hittinger G; Chouraqui M; Pisapia M; Delbeke E
J Acquir Immune Defic Syndr; 2001 Jan; 26(1):44-55. PubMed ID: 11176268
[TBL] [Abstract][Full Text] [Related]
28. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
30. Cytokine gene expression in HIV-infected intestinal mucosa.
McGowan I; Radford-Smith G; Jewell DP
AIDS; 1994 Nov; 8(11):1569-75. PubMed ID: 7848593
[TBL] [Abstract][Full Text] [Related]
31. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.
Clerici M; Seminari E; Suter F; Castelli F; Pan A; Biasin M; Colombo F; Trabattoni D; Maggiolo F; Carosi G; Maserati R
AIDS; 2000 Jan; 14(2):109-16. PubMed ID: 10708280
[TBL] [Abstract][Full Text] [Related]
32. The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects.
Osuji FN; Onyenekwe CC; Ahaneku JE; Ukibe NR
J Biomed Sci; 2018 Dec; 25(1):88. PubMed ID: 30501642
[TBL] [Abstract][Full Text] [Related]
33. Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.
Byrnes AA; Harris DM; Atabani SF; Sabundayo BP; Langan SJ; Margolick JB; Karp CL
J Leukoc Biol; 2008 Dec; 84(6):1447-53. PubMed ID: 18806124
[TBL] [Abstract][Full Text] [Related]
34. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.
Bucy RP; Hockett RD; Derdeyn CA; Saag MS; Squires K; Sillers M; Mitsuyasu RT; Kilby JM
J Clin Invest; 1999 May; 103(10):1391-8. PubMed ID: 10330421
[TBL] [Abstract][Full Text] [Related]
35. Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals.
Fernandes SM; Pires AR; Ferreira C; Foxall RB; Rino J; Santos C; Correia L; Poças J; Veiga-Fernandes H; Sousa AE
J Infect Dis; 2014 Aug; 210(4):630-40. PubMed ID: 24604817
[TBL] [Abstract][Full Text] [Related]
36. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
[TBL] [Abstract][Full Text] [Related]
37. Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue.
Talal AH; Monard S; Vesanen M; Zheng Z; Hurley A; Cao Y; Fang F; Smiley L; Johnson J; Kost R; Markowitz MH
J Acquir Immune Defic Syndr; 2001 Jan; 26(1):1-7. PubMed ID: 11176263
[TBL] [Abstract][Full Text] [Related]
38. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
Sereti I; Estes JD; Thompson WL; Morcock DR; Fischl MA; Croughs T; Beq S; Lafaye de Micheaux S; Yao MD; Ober A; Wilson EM; Natarajan V; Imamichi H; Boulassel MR; Lederman MM; Routy JP
PLoS Pathog; 2014 Jan; 10(1):e1003890. PubMed ID: 24497828
[TBL] [Abstract][Full Text] [Related]
39. Persistent HIV-1 replication does not explain low levels of T-cell interferon-gamma mRNA and elevated serum NO(2) (-)/NO(3) (-) in patients with stable CD4 T-cell responses to HAART.
Lee S; Almeida CA; French MA; Price P
Clin Exp Immunol; 2004 Oct; 138(1):110-5. PubMed ID: 15373912
[TBL] [Abstract][Full Text] [Related]
40. Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection.
Gonzalez SA; Zhang C; Fiel MI; Chung S; Zhang L; Jacobson IM; Talal AH
J Viral Hepat; 2008 May; 15(5):331-8. PubMed ID: 18179452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
